SacredBod's longer take on Evening Primrose Oil (Cervical) — context the structured blocks above don't capture.
Evening primrose oil (EPO) is extracted from the seeds of Oenothera biennis and is rich in gamma-linolenic acid (GLA, 7–14%), an omega-6 fatty acid with prostaglandin-like effects. It is used orally or vaginally in the last weeks of pregnancy to promote cervical ripening.
GLA is metabolized to dihomo-gamma-linolenic acid (DGLA), a precursor to series-1 prostaglandins (PGE1) that promote cervical softening and uterine contractility. Some studies suggest EPO improves Bishop score (a measure of cervical readiness), though meta-analyses are conflicting on whether this translates to shorter labor or reduced cesarean rates.
Who benefits most
Pregnant women at 37+ weeks gestation with an unfavorable cervix or post-term risk who want a natural adjunct to cervical ripening alongside standard obstetric care.
Dosage and form
1,000 mg is the typical effective range. Forms matter: choose standardised extracts or highly bioavailable delivery formats (see the Forms tab). Take as directed.
Side effects and cautions
Use only in last 4 weeks under OB supervision. Avoid if you: Do not use before 37 weeks due to risk of preterm labor. Avoid if you have a history of preterm birth, placenta previa, or are scheduled for elective cesarean. Discontinue if contractions become regular before term..
The evidence
Human clinical trials and mechanistic research support the use of Evening Primrose Oil (Cervical) for its primary indication. See the Research tab for full citations and study summaries.